Dirk Pamperin
Directeur/Membre du Conseil chez SYNTHAVERSE S.A.
Postes actifs de Dirk Pamperin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SYNTHAVERSE S.A. | Directeur/Membre du Conseil | 01/01/2020 | - |
APOGEPHA Arzneimittel GmbH
 APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Directeur Général | 01/01/2018 | - |
| Directeur Technique/Scientifique/R&D | 01/01/2012 | 01/01/2018 |
Historique de carrière de Dirk Pamperin
Anciens postes connus de Dirk Pamperin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Synthon BV
 Synthon BV Pharmaceuticals: MajorHealth Technology Synthon BV produces pharmaceutical products. Its activities include development, registration, production, marketing and distribution of pharmaceutical alternatives. The firm has operations in Europe, North America and Asia. The company was founded in 1991 by Jacques Lemmens and is headquartered in Nijmegen, the Netherlands. | Directeur Technique/Scientifique/R&D | 01/01/2005 | 01/01/2012 |
APOGEPHA Arzneimittel GmbH
APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Corporate Officer/Principal | 01/01/1998 | 01/01/2005 |
Formation de Dirk Pamperin
| Universität Stuttgart | Doctorate Degree |
| Technische Universität Braunschweig | Undergraduate Degree |
Statistiques
Internationale
| Allemagne | 4 |
| Pays-Bas | 2 |
| Pologne | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SYNTHAVERSE S.A. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Synthon BV
Synthon BV Pharmaceuticals: MajorHealth Technology Synthon BV produces pharmaceutical products. Its activities include development, registration, production, marketing and distribution of pharmaceutical alternatives. The firm has operations in Europe, North America and Asia. The company was founded in 1991 by Jacques Lemmens and is headquartered in Nijmegen, the Netherlands. | Health Technology |
APOGEPHA Arzneimittel GmbH
APOGEPHA Arzneimittel GmbH Medical/Nursing ServicesHealth Services APOGEPHA Arzneimittel GmbH engages in the research, development, marketing, and sale of pharmaceuticals in Urology. It offers drugs for the treatment of overactive bladder and urinary incontinence for adults and children. The firm also provides preparations for the treatment of urinary stone diseases, urinary tract infections, benign prostate syndrome, and bladder cancer. The company was founded by C. Stephan in 1882 and is headquartered in Dresden, Germany. | Health Services |
- Bourse
- Insiders
- Dirk Pamperin
- Expérience
